Thinking with Our Gut: How the Management of GI Conditions is Evolving
Through new diagnostic methods, integrated approaches and innovative management solutions, patients no longer have to…
Thinking with Our Gut: How the Management of GI Conditions is Evolving
Through new diagnostic methods, integrated approaches and innovative management solutions, patients no longer have to live with discomfort. Here are three major ways the GI field is evolving to better care for patients today. The post Thinking with Our Gut: How the Management of GI Conditions is Evolving appeared first on MedCity News.
Price Transparency Enforcement Is Still A Shared Responsibility
Despite all the noise around the updates, there’s one area that’s been conspicuously absent this year: enforcement of patient estimate requirements. The post Price Transparency Enforcement Is Still A Shared Responsibility appeared first on MedCity News.
The Burgeoning Life Science Ecosystem of North Texas, Anchored by Pegasus Park
[Sponsored] At INVEST Digital Health 2025, David Snow, Executive Director of Pegasus Park, discussed building a life science innovation hub and why life science startups at the North Texas campus are more likely to survive, scale, and exit. The post The Burgeoning Life Science Ecosystem of North Texas, Anchored by Pegasus Park appeared first on…
At Least 170 US Hospitals Face Major Flood Risk. Experts Say Trump Is Making It Worse.
https://kffhealthnews.org/wp-content/uploads/sites/2/2025/09/Video_Hospital-Flood-Risk_Grid.mp4 LOUISVILLE, Tenn. — When a big storm hits, Peninsula Hospital could be underwater. At this decades-old psychiatric hospital on the edge of the Tennessee River, an intense storm could submerge the building in 11 feet of water, cutting off all roads around the facility, according to a sophisticated computer simulation of flood risk. Aurora,…
Shutdown Halts Some Health Services as Political Risks Test Parties’ Resolve
Threats of a federal government shutdown have gone from being an October surprise to a recurring theme. This time around, though, the stakes are higher. Federal funding ran out at midnight on Oct. 1, after Congress failed to pass even a stopgap budget while negotiations continued. Now the question is how long the deadlock will…
Summon Your Spookiest Halloween Health Care Haikus
Sharpen your quills, brave souls. The spirits of health care bills past, present, and future are calling … and they demand haikus. Submissions are now open for KFF Health News’ seventh annual Halloween haiku competition. KFF Health News has been publishing reader-submitted health care haikus for years and is dying to read your frightful inspirations….
An Arm and a Leg: The Struggle To Afford Insurance in 2026 Hits Home
“An Arm and a Leg” senior producer Emily Pisacreta recently lost a job that provided her with health insurance. So now, for the first time, she will be signing up for Obamacare. Her search is off to a rocky start. Pisacreta gives listeners a sobering look at how the high price of health insurance plans…
Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs
September has seen a wide range of executive hires, exits, promotions and layoffs across the healthcare industry. For example, Medtronic, Amgen and Kaiser Permanente welcomed new executives. There were also layoffs at organizations including Novo Nordisk and Seattle Children’s. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity…
Pfizer Reaches Deal on Most-Favored Nation Drug Pricing; Other Pharmas Expected to Follow
Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored nation pricing agreement. But industry observers note that big pharma companies are also raising some prices overseas as part of a strategy to protect U.S. revenue. The post Pfizer Reaches Deal on Most-Favored Nation Drug Pricing;…
Two trends: Global pricing and ‘Pharm-to-table’
EndPoints notes that the Most Favored Nation Executive Order has led some large pharmaceutical firms to make two changes: (i) start charging Europeans the same price as the US, and (ii) start selling more products direct to consumer (a.k.a. ‘pharm to table‘) AbbVie, Novartis and Boehringer Ingelheim each joined their peers in making price-related concessions…
